These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26567956)

  • 1. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single circulating tumor cell sequencing as an advanced tool in cancer management.
    Salvianti F; Pazzagli M; Pinzani P
    Expert Rev Mol Diagn; 2016; 16(1):51-63. PubMed ID: 26560087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis.
    Court CM; Ankeny JS; Hou S; Tseng HR; Tomlinson JS
    Expert Rev Mol Diagn; 2015; 15(11):1491-504. PubMed ID: 26390158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer circulating tumor cells: applications for personalized oncology.
    DiPardo BJ; Winograd P; Court CM; Tomlinson JS
    Expert Rev Mol Diagn; 2018 Sep; 18(9):809-820. PubMed ID: 30099926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
    Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
    Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of circulating tumor cells-from bench to bedside.
    Li Y; Wu S; Bai F
    Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic potential of mutation detection from single circulating tumor cells in cancer patients.
    Salvianti F; Pinzani P
    Expert Rev Mol Diagn; 2017 Nov; 17(11):975-981. PubMed ID: 28931314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
    Ignatiadis M; Lee M; Jeffrey SS
    Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
    Miyamoto DT; Lee RJ
    Urol Oncol; 2016 Nov; 34(11):490-501. PubMed ID: 27771279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of single circulating tumor cells.
    Alix-Panabières C; Pantel K
    FEBS Lett; 2017 Aug; 591(15):2241-2250. PubMed ID: 28459503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
    Schlange T; Pantel K
    Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
    [No Abstract]   [Full Text] [Related]  

  • 12. Enumeration, Dielectrophoretic Capture, and Molecular Analysis of Circulating Tumor Cells.
    Yee SS; Carpenter EL
    Methods Mol Biol; 2017; 1634():193-202. PubMed ID: 28819852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using CTCs for pharmacogenomic analysis.
    Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
    Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenges for CTC-based liquid biopsies: low CTC frequency and diagnostic leukapheresis as a potential solution.
    Stoecklein NH; Fischer JC; Niederacher D; Terstappen LW
    Expert Rev Mol Diagn; 2016; 16(2):147-64. PubMed ID: 26587751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating tumor cells in breast cancer: applications in personalized medicine.
    Lee JS; Magbanua MJM; Park JW
    Breast Cancer Res Treat; 2016 Dec; 160(3):411-424. PubMed ID: 27761678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-Based Methods for Detection of Circulating Tumor Cells and Their Potential for Personalized Diagnostics.
    Zamay AS; Zamay GS; Kolovskaya OS; Zamay TN; Berezovski MV
    Adv Exp Med Biol; 2017; 994():67-81. PubMed ID: 28560668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.
    Alix-Panabières C; Pantel K
    Cancer Discov; 2016 May; 6(5):479-91. PubMed ID: 26969689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.
    Suh YS; Joung JY; Kim SH; Seo HK; Chung J; Lee KH
    Biomed Res Int; 2017; 2017():7206307. PubMed ID: 29230413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking cancer progression: from circulating tumor cells to metastasis.
    Castro-Giner F; Aceto N
    Genome Med; 2020 Mar; 12(1):31. PubMed ID: 32192534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.